1561 related articles for article (PubMed ID: 33510460)
1. Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma.
Llovet JM; De Baere T; Kulik L; Haber PK; Greten TF; Meyer T; Lencioni R
Nat Rev Gastroenterol Hepatol; 2021 May; 18(5):293-313. PubMed ID: 33510460
[TBL] [Abstract][Full Text] [Related]
2. Strategies to Improve the Antitumor Effect of Immunotherapy for Hepatocellular Carcinoma.
Xing R; Gao J; Cui Q; Wang Q
Front Immunol; 2021; 12():783236. PubMed ID: 34899747
[TBL] [Abstract][Full Text] [Related]
3. Evidence-Based Management of Hepatocellular Carcinoma: Systematic Review and Meta-analysis of Randomized Controlled Trials (2002-2020).
Haber PK; PuigvehĂ M; Castet F; Lourdusamy V; Montal R; Tabrizian P; Buckstein M; Kim E; Villanueva A; Schwartz M; Llovet JM
Gastroenterology; 2021 Sep; 161(3):879-898. PubMed ID: 34126063
[TBL] [Abstract][Full Text] [Related]
4. Progress in surgical and nonsurgical approaches for hepatocellular carcinoma treatment.
Yegin EG; Oymaci E; Karatay E; Coker A
Hepatobiliary Pancreat Dis Int; 2016 Jun; 15(3):234-56. PubMed ID: 27298100
[TBL] [Abstract][Full Text] [Related]
5. Combination of Ablation and Immunotherapy for Hepatocellular Carcinoma: Where We Are and Where to Go.
Wang K; Wang C; Jiang H; Zhang Y; Lin W; Mo J; Jin C
Front Immunol; 2021; 12():792781. PubMed ID: 34975896
[TBL] [Abstract][Full Text] [Related]
6. Locoregional radiological treatment for hepatocellular carcinoma; Which, when and how?
Meza-Junco J; Montano-Loza AJ; Liu DM; Sawyer MB; Bain VG; Ma M; Owen R
Cancer Treat Rev; 2012 Feb; 38(1):54-62. PubMed ID: 21726960
[TBL] [Abstract][Full Text] [Related]
7. Why Adjuvant and Neoadjuvant Therapy Failed in HCC. Can the New Immunotherapy Be Expected to Be Better?
Dikilitas M
J Gastrointest Cancer; 2020 Dec; 51(4):1193-1196. PubMed ID: 32869146
[TBL] [Abstract][Full Text] [Related]
8. Yttrium-90 microsphere radioembolisation for unresectable hepatocellular carcinoma.
Abdel-Rahman OM; Elsayed Z
Cochrane Database Syst Rev; 2016 Feb; 2():CD011313. PubMed ID: 26905230
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant and adjuvant treatment strategies for hepatocellular carcinoma.
Akateh C; Black SM; Conteh L; Miller ED; Noonan A; Elliott E; Pawlik TM; Tsung A; Cloyd JM
World J Gastroenterol; 2019 Jul; 25(28):3704-3721. PubMed ID: 31391767
[TBL] [Abstract][Full Text] [Related]
10. Goals and targets for personalized therapy for HCC.
Couri T; Pillai A
Hepatol Int; 2019 Mar; 13(2):125-137. PubMed ID: 30600478
[TBL] [Abstract][Full Text] [Related]
11. Interventional treatment for unresectable hepatocellular carcinoma.
Murata S; Mine T; Sugihara F; Yasui D; Yamaguchi H; Ueda T; Onozawa S; Kumita S
World J Gastroenterol; 2014 Oct; 20(37):13453-65. PubMed ID: 25309076
[TBL] [Abstract][Full Text] [Related]
12. Image-guided percutaneous locoregional therapies for hepatocellular carcinoma.
Chevallier O; Zhao K; Marinelli B; Yarmohammadi H
Chin Clin Oncol; 2023 Apr; 12(2):17. PubMed ID: 37081710
[TBL] [Abstract][Full Text] [Related]
13. Combination therapies plus transarterial chemoembolization in hepatocellular carcinoma: a snapshot of clinical trial progress.
Brown ZJ; Hewitt DB; Pawlik TM
Expert Opin Investig Drugs; 2022 Apr; 31(4):379-391. PubMed ID: 34788184
[TBL] [Abstract][Full Text] [Related]
14. Local-regional treatment of hepatocellular carcinoma.
Lencioni R; Crocetti L
Radiology; 2012 Jan; 262(1):43-58. PubMed ID: 22190656
[TBL] [Abstract][Full Text] [Related]
15. Management of hepatocellular in the United States.
Mokdad AA; Hester CA; Singal AG; Yopp AC
Chin Clin Oncol; 2017 Apr; 6(2):21. PubMed ID: 28482674
[TBL] [Abstract][Full Text] [Related]
16. Current Standard and Future Perspectives in Non-Surgical Therapy for Hepatocellular Carcinoma.
Eggert T; Greten TF
Digestion; 2017; 96(1):1-4. PubMed ID: 28605745
[TBL] [Abstract][Full Text] [Related]
17. Locoregional therapy for hepatocellular carcinoma.
Guimaraes M; Uflacker R
Clin Liver Dis; 2011 May; 15(2):395-421, vii-x. PubMed ID: 21689621
[TBL] [Abstract][Full Text] [Related]
18. What's New in Percutaneous Ablative Strategies for Hepatocellular Carcinoma and Colorectal Hepatic Metastases? 2020 Update.
Arellano RS
Curr Oncol Rep; 2020 Jul; 22(10):105. PubMed ID: 32725433
[TBL] [Abstract][Full Text] [Related]
19. Comparative effectiveness of different transarterial embolization therapies alone or in combination with local ablative or adjuvant systemic treatments for unresectable hepatocellular carcinoma: A network meta-analysis of randomized controlled trials.
Katsanos K; Kitrou P; Spiliopoulos S; Maroulis I; Petsas T; Karnabatidis D
PLoS One; 2017; 12(9):e0184597. PubMed ID: 28934265
[TBL] [Abstract][Full Text] [Related]
20. The Timing of Liver Transplantation Following Downstaging: Wait of Not to Wait?
Ersan V; Barut B; Yilmaz S
J Gastrointest Cancer; 2020 Dec; 51(4):1152-1156. PubMed ID: 32856230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]